Invention Grant
- Patent Title: Prodrugs
- Patent Title (中): 前药
-
Application No.: US13255812Application Date: 2010-03-09
-
Publication No.: US08642555B2Publication Date: 2014-02-04
- Inventor: Felix Kratz , Andre Warnecke , Bakheet Elsadek
- Applicant: Felix Kratz , Andre Warnecke , Bakheet Elsadek
- Applicant Address: DE Freibur im Breisgau
- Assignee: KTB Tumorforschungsgesellschaft mbH
- Current Assignee: KTB Tumorforschungsgesellschaft mbH
- Current Assignee Address: DE Freibur im Breisgau
- Agency: Knobbe, Martens, Olson & Bear, LLP
- Priority: EP09003410 20090309
- International Application: PCT/EP2010/001461 WO 20100309
- International Announcement: WO2010/102788 WO 20100916
- Main IPC: A61K38/08
- IPC: A61K38/08
Abstract:
The present invention relates to a prodrug comprising at least one cytostatic agent, wherein said prodrug is cleavable by prostate-specific antigen (PSA), a process for preparing said prodrug and a pharmaceutical composition containing said prodrug in a pharmaceutically effective amount, for use in the treatment of cancer.
Public/Granted literature
- US20120094892A1 PRODRUGS Public/Granted day:2012-04-19
Information query
IPC分类:
